“COVAX works” the head of the World Health Organization (WHO) said on Friday, informing journalists that the UN-backed vaccine initiative has distributed more than 32 million vaccines to 61 countries in just one month.
COVAX
WHO, UNICEF and Partners Receive First Batch of Billion Dollars Project of COVID-19 Vaccines
Sierra Leone country representatives of WHO, unicef, and other partners receive the first batch of 96,000 doses of Astra Seneca COVID-19 vaccines under the COVAX Facility.
COVID-19 vaccination ‘wildly uneven and unfair’: UN Secretary-General
International partners working to achieve equitable distribution of COVID-19 vaccines appealed on Wednesday for the UN Security Council to ensure people caught in conflict have access to these lifesaving treatments.
WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out
The World Health Organization (WHO) on Monday listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.
COVAX warns SARS-CoV-2 is reminder viruses by their very nature mutate
The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt to remain effective against them, according to COVAX statement on new variants of SARS-CoV-2.
Joint statement by UNICEF Executive Director Henrietta Fore and WHO Director-General Dr. Tedros Adhanom Ghebreyesus
Of the 128 million vaccine doses administered so far, more than three quarters of those vaccinations are in just 10 countries that account for 60% of global GDP.
Ghana faces hurdles to achieve targets set for COVID-19 vaccine rollout
Ghana, like many of its counterparts on the continent, is contending with the fallout from the rapid spread of SARS-CoV-2 variants. Of particular concern is the B.1.1.7 variant first identified in the UK. It is estimated to be up to 70% more infectious and 65% more lethal than the ancestral strain.